Literatur
- 1
Beiter A, Lewis K, Pindea E F, Cherry J D.
Unrecognized
maternal peripartum pertussis with subsequent fatal neonatal pertussis.
Obstet
Gynecol.
1993;
82
691-693
- 2
Cherry J D, Baraff L J, Hawlett E.
The
past, present and future of pertussis in families: the role of adults
in epidemiology and future control (specialty conference).
West
J Med.
1989;
150
319-328
- 3
Cherry J D.
Acellular
pertussis vaccines - a solution to the pertussis problem.
J
Infect Dis.
1993;
168
21-24
- 4
Cherry J D, Beer T, Chartrand S A. et al .
Comparison of antibody values to Bordetella
pertussis antigens in young German and American men.
Clin
Infect Dis.
1995;
20
1271-1274
- 5
Cone T E.
Whooping
cough is first described as a disease sui generis by Baillou in
1640.
Pediatrics.
1970;
46
522
- 6
Deville J G, Cherry J D, Christenson P D. et al .
Frequency of unrecognized Bordetella pertussis
infections in adults.
Clin Infect Dis.
1995;
21
639-642
- 7
Edwards K M, Decker M D, Graham B S, Mezzatesta J, Scott J, Hackell J.
Adult immunization with
acellular pertussis vaccine.
JAMA.
1993;
269
53-56
- 8
Edwards K M.
Acellular
pertussis vaccines - a solution to the pertussis problem.
J
Infect Dis.
1993;
168
15-20
- 9
Fine P EM.
Adult
Pertussis: A salesman¿s dream - and an epidemiologist¿s
nightmare.
Biologicals.
1997;
25
195-198
- 10
Granström M, Thorén M, Blennow M, Tiru M, Sato Y.
Acellular
pertussis vaccine in adults: adverse reactions and immune response.
Eur
J Clin Microbiol.
1987;
6
18-21
- 11
Halperin S A, Marrie T J.
Pertussis encephalopathy
in an adult. Case report and review.
Rev Infect Dis.
1991;
13
1043-1047
- 12
Halperin S A, Smith B, Russell M. et al .
An adult formulation of a five-component
acellular pertussis vaccine combined with diphtheria and tetanus
toxoids is safe and immunogenic in adolescents and adults.
Vaccine.
2000;
18
1312-1319
- 13
Heininger U, Cherry J D, Eckhardt T, Lorenz C, Christenson P, Stehr K.
Clinical and laboratory
diagnosis of pertussis in the regions of a large vaccine efficacy
trial in Germany.
Pediatr Infect Dis J.
1993;
12
504-509
- 14
Heininger U, Cherry J D, Christenson P. et al .
Comparative study of Lederle/Takeda
acellular and whole-cell pertussis component diphtheria-tetanus-pertussis
vaccines in infants in Germany.
Vaccine.
1994;
12
81-86
- 15
Hennes H.
Der
Keuchhusten bei Erwachsenen.
Medizinische Klinik.
1921;
20
591-593
- 16
Herwaldt L A.
Pertussis
and pertussis vaccines in adults.
JAMA.
1993;
269
93-94
- 17
Keitel W A, Muenz L R, Decker M D. et al .
A randomized clinical trial of acellular
pertussis vaccines in healthy adults: dose-response comparisons
of 5 vaccines and implications for booster immunization.
J
Infect Dis.
1999;
180
397-403
- 18
Kurt T L, Yaeger A S, Guenette S, Dulop S.
Spread of pertussis by
hospital staff.
JAMA.
1972;
221
264-267
- 19
Lin T Y, Chian B L.
Specific immune
responses in adult medical personnel immunized with acellular pertussis
vaccine with special emphasis on T helper cell response.
Vaccine.
1997;
15
1917-1921
- 20
Lugauer S, Jüngert J, Kübel F, Heininger U, Stehr K.
Verträglichkeit und
Immunogenität einer kombinierten Diphtherie-, Tetanus-, azellulären
Pertussis-(DTaP)Impfung im Erwachsenenalter (abstract).
Monatsschr
Kinderheilk.
1997;
145
1123
- 21
Mink C, Cherry J, Christenson P. et al .
A
search for Bordetella pertussis infection in university students.
Clin
Infect Dis.
1992;
14
464-471
- 22 Mink C, Froeschle J, Miller B, Duane C, Hosbach P, Gravenstein S. Safety and immunogenicity
of diphtheriea and Tetanus toxoid adsorbed with a 2 component acelluar
pertussis vaccine (TdacP) in adults. 32nd annual meeting
(1994) of Infectious Diseases Society of America, Orlando Abstract
230
- 23
Nenning M E, Shinefield H R, Edwards K M, Black S B, Fireman B H.
Prevalence
and incidence of adult pertussis in an urban population.
JAMA.
1996;
275
1672-1674
- 24
Neurath R.
Der
Keuchhusten bei Erwachsenen.
Med Klin.
1921;
39
1173
- 25
Postels-Multani S, Schmitt H J, Wirsing von
König C H, Bock H L, Bogaerts H.
Symptoms and complications
of pertussis in adults.
Infection.
1995;
23
139-142
- 26
Robertson P W, Goldberg H, Jarvie B H, Smith B H, Whybin L R.
Bordetella
pertussis infection: a cause of persistent cough in adults.
Med
J Aust.
1987;
146
522-525
- 27
Rothstein E P, Anderson E L, Decker M D. et al .
An acellular pertussis vaccine in healthy
adults: safety and immunogenicity.
Vaccine.
1999;
17
2999-3006
- 28
Rutter D A, Ashworth L AE, Day A, Funnell S, Lovell F, Robinson A.
Trial of a new acellular
pertussis vaccine in healthy adult volunteers.
Vaccine.
1988;
6
29-32
- 29
Ruuskanen O, Noel A, Putto-Laurila A. et al .
Development of an acellular pertussis vaccine
and its administration as a booster in healthy adults.
Vaccine.
1991;
9
117-121
- 30 Saemann-Ischenko G, Tillmanns B, Schmitt H J, König von Wirsing C H. Low
rate of asymptomatic contacts in german adults. 38th
Interscience conference on antimicrobial agents and chemotherapy (ICAAC) 1998: G-57
- 31
Schmitt H J, Mohnike K, Zepp F, Herden P, Hosbach P.
Immunogenicity and reactogenicity
of the Biken acellular pertussis vaccine in young adults.
Vaccine.
2001;
19
403-408
- 32
Schmitt-Grohé S, Cherry J D, Heininger U, Überall M A, Pineda E, Stehr K.
Pertussis in German adults.
Clin
Infect Dis.
1995;
21
860-866
- 33
Schwenkenbecher A.
Keuchhusten
bei Erwachsenen.
Med Klin.
1921;
48
1447-1448
- 34
Shefer A, Dales L, Nelson M, Werner B, Baron R, Jackson R.
Use
and safety of acellular pertussis vaccine among adult hospital staff
during an outbreak of pertussis.
J Infect Dis.
1995;
171
1053-1056
- 35
Stehr K, Lugauer S, Heininger U, Uhlenbusch R, Cherry J D.
Verträglichkeit
und Immunogenität der Keuchhustenimpfung mit einem azellulären
monovalenten 4-Komponenten-Impfstoff (Lederle/Takeda) bei
185 Erwachsenen.
Pädiatr Grenzgeb.
1995;
34
219-223
- 36
Stehr K, Heininger U, Uhlenbusch R, Angersbach P, Hackell J, Eckardt T.
Immunogenicity
and safety of a monovalent, multicomponent acellular pertussis vaccine
in 15 month - 6-year-old German children.
Eur
J Pediatr.
1995;
154
209-214
- 37
Stehr K, Cherry J D, Heininger U. et al .
A
comparative efficacy trial in Germany in infants who received either
the Lederle/Takeda acellular pertussis component DTP (DTaP)
vaccine, the Lederle whole-cell component DTP or DT vaccine.
Pediatrics.
1998;
101
1-11
- 38
Steketee R W, Wassilak S G, Adkins W N, Burstyn D G, Manclark C R, Berg J.
Evidence for a high attack
rate and efficacy of erythromycin prophylaxis in a pertussis outbreak
in a facility for the developmentally disabled.
J Infect
Dis.
1988;
157
434-440
- 39
Swidsinski S.
Pertussis
in Deutschland.
Epidemiol Bull.
1996;
323-327
- 40
Turnbull F M, Heath T C, Jalaludin B B, Burgess M A, Ramalho A C.
A randomized
trial of two acellular pertussis vaccines (dTpa and pa) and a licensed
diphtheria-tetanus vaccine (Td) in adults.
Vaccine.
2001;
19
628-636
- 41
Valenti W M, Pincus P H, Messner M K.
Nosocomial
Pertussis: possible spread by a hospital visitor.
AJDC.
1980;
134
520-521
- 42
Van der Wielen M, Van Damme P, Joossens E, François, Meurice F, Ramalho A.
A randomised controlled
trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine
in adults.
Vaccine.
2000;
18
2075-2082
- 43
Wirsing von König C H, Tacken A, Finger H.
Keuchhusten
bei Erwachsenen.
Dtsch Med Wochenschr.
1991;
116
649-653
- 44
Wirsing von König C H, Postels-Multani S, Bock H L, Schmitt H J.
Pertussis
in adults: frequency of transmission after household exposure.
Lancet.
1995;
346
1326-1329
- 45
Wirsing von König C H, Postels-Multani S, Bogaerts H. et al .
Factors influencing the spread of pertussis
in households.
Eur J Pediatr.
1998;
157
391-394
- 46
Wirsing von König C H, Gounis D, Laukamp S, Bogaerts H, Schmitt H J.
Evaluation
of a single-sample serological technique for diagnosing pertussis
in unvaccinated children.
Eur J Clin Microbiol Infect Dis.
1999;
18
341-345
Korrespondenz
Privatdozent Dr. Ulrich Heininger
Universitäts-Kinderspital beider Basel (UKBB)
Postfach
CH-4005 Basel
Phone: 0041/61/685 6565
Fax: 0041/61/685 6012
Email: Ulrich.Heininger@unibas.ch
